-
CAF president visits Dakar following AFCON trophy reversal
-
Medvedev thrashed 6-0, 6-0 by Berrettini in Monte Carlo
-
Australia's O'Callaghan sets sights on Titmus's 200m freestyle world record
-
Oil prices plunge, stocks surge on US-Iran ceasefire
-
Researchers unmask trade in nude images on Telegram
-
Warner aware of 'seriousness' of drink-driving charges: Cricket NSW
-
Indian hit movie 'Dhurandhar' breaks Bollywood records
-
Australia PM welcomes Iran ceasefire, says Trump threats not 'appropriate'
-
Nigeria sweats in heatwave as Iran war drives up costs to stay cool
-
'Pinprick of light': Artemis crew witnesses meteorite impacts on Moon
-
German factory orders rise in February but energy shock looms
-
China says investigating 'malicious' cyberbullying of teen diving star
-
North Korea fires two rounds of ballistic missiles: Seoul military
-
Taiwan opposition leader says China visit to sow 'seeds of peace'
-
Jet fuel supplies to take 'months' to recover from war disruption: IATA
-
How did Pakistan broker a temporary truce between Iran and the US?
-
North Korea fires multiple ballistic missiles in two rounds: Seoul military
-
Rockets comeback sinks Phoenix on Durant return
-
'Ketamine Queen' to be sentenced over Matthew Perry death
-
Vietnam's To Lam bets big on building blitz
-
Sooryavanshi, 15, hailed as 'amazing, fearless' after acing Bumrah test
-
Pakistan to host US-Iran ceasefire talks Friday
-
Middle East war: ceasefire reactions
-
North Korea fires multiple ballistic missiles towards East Sea
-
Both sides claim victory after US, Iran agree to 11th-hour truce
-
Unbeaten legend Winx's $7 million foal retires without racing
-
Trump to AFP: Iran deal 'total and complete victory' for US
-
Solar push helps Pakistan temper Gulf energy shock
-
Crude prices plunge, stocks surge as US and Iran agree ceasefire
-
Wave of nostalgia as 2000s TV makes a comeback
-
Iraqi armed group releases US journalist
-
Forest's Igor Jesus eyes Europa League 'dream', Villa brace for Bologna in quarters
-
In-demand prop De Lutiis rebuffs Ireland to commit to Australia
-
US, Iran agree to 11th-hour truce after Trump apocalyptic threats
-
Ainos, MacKay Memorial Hospital and Topco Scientific Partner to Advance Smell AI Deployment in High-Risk Hospital Environments
-
NextTrip Partners with QSTAK to Launch Tokenized Rewards and Unlock New Revenue Opportunities
-
Marketing Security Demos Head to Digital Marketing Europe 2026
-
RETRANSMISSION: Dallas Nail Spa Draws Large Crowds Following Launch of Unlimited Membership Model
-
Gold Terra Announces Assay Results of 22.46 g/t Gold over 5.2 Metres in the Walsh Lake Area, Northbelt, NWT
-
The Metals Royalty Company Inc. to Commence Trading on the Nasdaq Capital Market Under the Symbol "TMCR"
-
Mosaic Announces Idling Of Araxá And Patrocínio Facilities And Pursuit Of Sale Of Araxá Assets
-
Marijuana Rescheduling Countdown: Why the "Order of Operations" and Todd Blanche's Appointment Define the Path to Schedule III
-
New Birth Injury Resource Center Launches as Data Shows Thousands of Newborns Face Preventable Complications Each Year
-
Kingfisher Appoints Sharon G.K. Singh to Board of Directors
-
Rad Source Technologies Activates a Wealth of Peer-Reviewed Data with Bioz Badges to Strengthen Customer Use-Case Visibility
-
Tocvan Announces Addition of Second Drill Rig and Accelerates High-Priority Drill Targets at Flagship Gran Pilar Gold-Silver Project
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - April 08
-
Trump suspends Iran bombing for two weeks, after apocalyptic threats
-
Latest Anthropic AI model finds cracks in software defenses
-
McIlroy chases Masters repeat at lightning-fast Augusta
Yunu Extends from Site Imaging Standard to Central Review Workflow Leader
New Imaging Automation Delivers a Modern Framework for Central Review & Site Collaboration
CARY, NORTH CAROLINA / ACCESS Newswire / January 29, 2026 / As the clinical research industry looks toward SCOPE 2026, one reality remains clear: imaging has become increasingly essential to trial science, yet the operational models supporting it are reaching a breaking point. For years, clinical trial imaging has relied on fragmented systems, manual processes, and service-laden workarounds that no longer align with the quality, speed, and transparency requirements of sponsors.

Yunu is changing that equation. Built as a fit-for-purpose trial imaging platform, Yunu offers a tech-forward alternative that dramatically reduces project management work, eliminates delays, and accelerates the radiology reading process while keeping everyone connected, efficient, and informed.
From Fragmented Site-Central Practices to a Unified Standard
As the market share leader across NCI Comprehensive Cancer Centers, Yunu's rapid adoption has reshaped how imaging is performed and managed at scale. What began as a solution trusted by sites is now becoming a strategic platform for sponsors, who are increasingly adopting Yunu to bring greater rigor, confidence, and consistency into central review workflows. By embedding sponsor-specific requirements directly into workflow logic, Yunu's latest release brings the same efficient experience sites already rely on into the heart of trial imaging oversight.
The result is a single, shared environment where sites and sponsors operate with aligned standards, controlled visibility, and consistent execution, while reducing layers of coordination, dependency, and overhead. Yunu transforms trial imaging from a series of handoffs into a unified, end-to-end experience.
"Clinical trial imaging is breaking under the load of a combination of people, manual processes, and patchwork systems that hold it together," said Jeff Sorenson, Chief Executive Officer at Yunu. "Sponsors now recognize that the solution is not more outsourcing, but a thoughtful technology framework designed to carry more of the scientific and operational weight for them."
Engage with Yunu at SCOPE 2026
Yunu is signaling what comes next: a future where clinical trial imaging is powered by smart workflow, not manual effort. SCOPE Annual Summit attendees can meet with Yunu leadership and trial imaging experts at exhibit #201 in Orlando, Florida, February 2nd-5th, 2026.
About Yunu
Yunu is a clinical imaging data platform transforming how life sciences organizations manage, share, and analyze imaging data for clinical trials. Designed to meet the highest standards of compliance and collaboration, Yunu enables faster, cleaner, and more transparent imaging workflows from site to submission across a growing global community using Yunu every day. For more information, visit yunu.io and Request a Demo.
Contact:
Lindsay Fleming
Chief Marketing Officer
[email protected]
SOURCE: Yunu
View the original press release on ACCESS Newswire
J.Gomez--AT